Zhiqiang Q. Song
168 Changhai Road
Shanghai, 200433, China
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 130 publications
Chronic Spontaneous Urticaria Combined Atopic Dermatitis/Other Atopic Comorbidities: Clinical Characteristics, Therapeutic Response to Omalizumab, and Drug Survival.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: May 29, 2026
Real-world outcomes of 24-week abrocitinib tapering in moderate-to-severe atopic dermatitis: Feasibility and regimen comparison.
Journal: Journal of the American Academy of Dermatology
Published: May 19, 2026
Efficacy and Safety of Tofacitinib in the Treatment of Refractory Chronic Spontaneous Urticaria: A Real-World Study.
Journal: Journal of the American Academy of Dermatology
Published: May 17, 2026
Phototherapy for Acne Vulgaris: Strategies and Clinical Applications in Sebum Modulation, Inflammation Control, and Scar Management.
Journal: Photobiomodulation, photomedicine, and laser surgery
Published: April 14, 2026
Clinical practice guideline for H1 antihistamine-resistant Chronic Spontaneous Urticaria.
Journal: Asian Pacific journal of allergy and immunology
Published: November 03, 2025
Predictors of Super/Poor Omalizumab Response in Chinese Refractory Chronic Spontaneous Urticaria.
Journal: Dermatology (Basel, Switzerland)
Published: November 02, 2025
Clinical distribution patterns and histopathological features of 2016 cases of basal cell carcinoma: a retrospective study from Southwest China.
Journal: European journal of medical research
Published: November 01, 2025
52-week ivarmacitinib in moderate-to-severe atopic dermatitis: A phase 3 trial.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 28, 2025
Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Erythematotelangiectatic Rosacea: A Randomized Clinical Trial.
Journal: JAMA dermatology
Published: October 08, 2025
Efficacy and Safety Comparisons of Four Approved Chimeric Antigen Receptor T-Cell Therapies in Multiple Myeloma.
Journal: Hematological oncology
Published: September 22, 2025
Tofacitinib for the Treatment of Refractory Severe Acute Urticaria: A Retrospective Case Series.
Journal: American journal of therapeutics
Published: September 18, 2025
Safety profile of vunakizumab in elderly patients with moderate-to-severe plaque psoriasis: a post-hoc analysis.
Journal: Frontiers in medicine
Published: September 09, 2025
Last Updated: 09/26/2026